ADBiotech Co (179530.KQ) Stock Price

ADBiotech Co Price

CLOSED
2,185.00
​
Market closed

Revenue has compounded at 9.2% per year over the past 11 years to 12.90 B KRW. Earnings per share have grown at 34.3% per year over the last 5 years. ADBiotech Co's net margin stands at -25.6%, down from -22.5% several years earlier.

ADBiotech Co stock price

Access this data via the Eulerpool API

ADBiotech Co business model & stock analysis

ADbiotech Co., Ltd. engages in the research and development of chemical products for pharmaceuticals, stockbreeding, and fisheries. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2019-12-24. The firm operates its business through two segments. Veterinary Medicine segment is engaged in the manufacture and sale of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, synthetic antibacterial agents and others. The Supplementary Feed segment is engaged in the manufacture and sale of functional supplementary feeds and other products.

Frequently asked questions about ADBiotech Co

Converted at the current exchange rate, the ADBiotech Co share trades at 1.45 EUR (2,185.00 KRW).

The revenue cannot currently be calculated for ADBiotech Co.

The profit cannot currently be calculated for ADBiotech Co.

The P/E ratio cannot be calculated for ADBiotech Co at the moment.

The P/S cannot be calculated for ADBiotech Co currently.

The Eulerpool Quality Score for ADBiotech Co is 2/10.

The ISIN of ADBiotech Co is KR7179530001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of ADBiotech Co is 179530.KQ. The ticker symbol is used to trade ADBiotech Co shares on the stock exchange.

Fair ValueTerminal
1,988.35 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Dec 24, 2019
ISIN
KR7179530001
Cusip
Y0R19B108
Market capitalization
19.97 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.30
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-18.01 %
Last updated Oct 7, 2026, 10:05 PM

ADBiotech Co Peer Group

ADBiotech Co FIGI

179530:KS · BBG00R496JZ0179530:KQ · BBG00R496K14

All fundamentals and in-depth analysis of ADBiotech Co

Our stock analysis for ADBiotech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ADBiotech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.